BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21868263)

  • 21. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
    Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
    Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma.
    Elliott NE; Cleveland SM; Grann V; Janik J; Waldmann TA; Davé UP
    Blood; 2011 Oct; 118(14):3911-21. PubMed ID: 21821710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.
    Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X
    J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced gene expression of bikunin as a prognostic marker for renal cell carcinoma.
    Bayraktar E; Igci M; Erturhan S; Igci YZ; Karakok M; Gogebakan B; Ulasli M; Cakmak EA; Arslan A
    Exp Oncol; 2014 Jun; 36(2):107-11. PubMed ID: 24980765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.
    Ehrentraut S; Schneider B; Nagel S; Pommerenke C; Quentmeier H; Geffers R; Feist M; Kaufmann M; Meyer C; Kadin ME; Drexler HG; MacLeod RA
    Oncotarget; 2016 Jun; 7(23):34201-16. PubMed ID: 27144517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.
    Di Matteo G; Chiriaco M; Scarselli A; Cifaldi C; Livadiotti S; Di Cesare S; Ferradini V; Aiuti A; Rossi P; Finocchi A; Cancrini C
    Mol Genet Genomic Med; 2018 Sep; 6(5):713-721. PubMed ID: 30032486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W; Uemura M; Sato M; Fujita K; Jingushi K; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Oncotarget; 2015 Aug; 6(25):21645-54. PubMed ID: 26046464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.
    Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP
    Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.
    Du Y; Su T; Tan X; Li X; Xie J; Wang G; Shen J; Hou J; Cao G
    Gene; 2013 Jan; 512(1):64-9. PubMed ID: 23069849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma.
    Jafri M; Wake NC; Ascher DB; Pires DE; Gentle D; Morris MR; Rattenberry E; Simpson MA; Trembath RC; Weber A; Woodward ER; Donaldson A; Blundell TL; Latif F; Maher ER
    Cancer Discov; 2015 Jul; 5(7):723-9. PubMed ID: 25873077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
    Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
    Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
    Safarinejad MR
    BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
    Choi JW; Lee JH; Park HS; Kim YS
    J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
    Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
    Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
    Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
    Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.